SEC Form 4 · accession 0001140361-15-038160
Apyx Medical Corp · APYX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jay D. Ewers
Officer — Chief Financial Officer
Period of report
Oct 14, 2015
Accepted (ET)
Oct 21, 2015 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000719135
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Option to Buy)F1 | $2.13 | Oct 14, 2015 | A | 65,000 | A | Oct 14, 2015 | Oct 14, 2025 | Common Stock | 65,000 | 65,000 | D |
Explanation of responses
- F1Reporting person was granted a stock option which shall vest ratably over a four (4) year period.